The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas

The aim of SWOAR TRIAL is to test sparing of Dysphagia/ Aspiration risk structures (DARS) and contra lateral submandibular gland by IMRT. HNSCC of the oropharynx, larynx and the hypopharynx treated with radical concurrent chemoradiotherapy or radiotherapy will be included in the trial. Patients will be randomized to SWOAR IMRT or standard IMRT. Swallowing function will be evaluated the MD Anderson Dysphagia Inventory (MDADI) scoring. Difference in the mean composite score of MDADI, a patient-reported outcome, at 6 months post radiotherapy is the primary outcome of the trial. Secondary Object

Trial Details

NCT ID
NCT05187091
Phase
PHASE3
Sponsor
All India Institute of Medical Sciences
Status
RECRUITING
Cancer Type
Squamous Cell Head and Neck Cancer
Interventions
  • Swallowing and submandibular sparing IMRT
  • Standard IMRT with medical CRT/RT
  • Cisplatine
Locations (sample)
  • Jhajjar, Haryana, India|28.6063,76.6565

Key Eligibility Criteria

  • Aged 18 or above and less than 70 years
  • Patient undergoing radiotherapy for HNSCC of the Oropharynx or Larynx or Hypopharynx.
  • Stage T1-4, N0-3, M0 disease with histologically confirmed squamous cell carcinoma requiring bilateral neck radiotherapy and where sparing of contr…
  • Radiotherapy with concomitant chemotherapy (unless contraindicated) is the planned treatment

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Squamous Cell Head and Neck Cancer Trials on Trialify →